Patents by Inventor Anshul Chaudhary

Anshul Chaudhary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods related to ebolavirus vaccines
    Patent number: 11872277
    Abstract: The present invention provides novel engineered Ebolavirus GP proteins and polypeptides, scaffolded vaccine compositions that display the engineered proteins, and polynucleotides encoding the engineered proteins and scaffolded vaccine compositions. The invention also provides methods of using such engineered Ebolavirus GP proteins and vaccine compositions in various therapeutic applications, e.g., for preventing or treating Ebolavirus infections.
    Type: Grant
    Filed: April 7, 2022
    Date of Patent: January 16, 2024
    Assignee: The Scripps Research Institute
    Inventors: Linling He, Jiang Zhu, Anshul Chaudhary, Ian Wilson
  • COMPOSITIONS AND METHODS RELATED TO EBOLAVIRUS VACCINES
    Publication number: 20220305109
    Abstract: The present invention provides novel engineered Ebolavirus GP proteins and polypeptides, scaffolded vaccine compositions that display the engineered proteins, and polynucleotides encoding the engineered proteins and scaffolded vaccine compositions. The invention also provides methods of using such engineered Ebolavirus GP proteins and vaccine compositions in various therapeutic applications, e.g., for preventing or treating Ebolavirus infections.
    Type: Application
    Filed: April 7, 2022
    Publication date: September 29, 2022
    Inventors: Linling He, Jiang Zhu, Anshul Chaudhary, Ian Wilson
  • Compositions and methods related to ebolavirus vaccines
    Patent number: 11305004
    Abstract: The present invention provides novel engineered Ebolavirus GP proteins and polypeptides, as well as scaffolded vaccine compositions that display the engineered proteins. The invention also provides methods of using such engineered Ebolavirus GP proteins and vaccine compositions in various therapeutic applications, e.g., for preventing or treating Ebolavirus infections.
    Type: Grant
    Filed: August 9, 2021
    Date of Patent: April 19, 2022
    Assignee: The Scripps Research Institute
    Inventors: Linling He, Jiang Zhu, Anshul Chaudhary, Ian Wilson
  • COMPOSITIONS AND METHODS RELATED TO EBOLAVIRUS VACCINES
    Publication number: 20220040286
    Abstract: The present invention provides novel engineered Ebolavirus GP proteins and polypeptides, as well as scaffolded vaccine compositions that display the engineered proteins. The invention also provides methods of using such engineered Ebolavirus GP proteins and vaccine compositions in various therapeutic applications, e.g., for preventing or treating Ebolavirus infections.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 10, 2022
    Inventors: Linling He, Jiang Zhu, Anshul Chaudhary, Ian Wilson